37525413|t|Altered properties of amyloidogenic prion protein in genetic Creutzfeldt-Jakob disease with PRNP V180I mutation in response to pentosan polysulfate.
37525413|a|Genetic Creutzfeldt-Jakob disease (gCJD) with V180I prion protein gene (PRNP) mutation shows weaker prion protein (PrP) deposition histologically compared with sporadic CJD, and it is more difficult to detect protease-resistant prion protein in immunoblotting. However, we previously reported the autopsy case of a patient with V180I gCJD who was treated with pentosan polysulfate sodium (PPS); this case had increased protease-resistant PrP deposition. It has been suggested that PPS might reduce protease-resistant PrP; however, the detailed pharmacological and histopathological effects of PPS in humans remain unknown. We examined autopsied human brain tissue from four cases with V180I gCJD that were added to our archives between 2011 and 2021: two cases treated with PPS and two cases without PPS. We conducted a neuropathological assessment, including immunohistochemistry for PrP. We also performed immunoblotting for PrP on homogenate samples from each brain to detect protease-resistant PrP using both a conventional procedure and size-exclusion gel chromatography for the purification of oligomeric PrP. Both PPS-treated cases showed long survival time over 5 years from onset and increased PrP deposition with a characteristic pattern of coarse granular depositions and congophilic PrP microspheres, whereas the cases without PPS showed around 1-year survival from onset and relatively mild neuronal loss and synaptic PrP deposition. Although cortical gliosis seemed similar among all cases, aquaporin 4-expression as a hallmark of astrocytic function was increased predominantly in PPS cases. Immunoblotting of non-PPS cases revealed protease-resistant PrP in the oligomeric fraction only, whereas the PPS-treated cases showed clear signals using conventional procedures and in the oligomeric fraction. These unique biochemical and histopathological changes may reflect the progression of V180I gCJD and its modification by PPS, suggesting the possible existence of toxic PrP-oligomer in the pathophysiology of V180I gCJD and beneficial effects of PPS toward the aggregation and detoxication of toxic PrP-oligomer.
37525413	61	86	Creutzfeldt-Jakob disease	Disease	MESH:D007562
37525413	97	102	V180I	ProteinMutation	tmVar:p|SUB|V|180|I;HGVS:p.V180I;VariantGroup:0;CorrespondingGene:5621;RS#:74315408;CorrespondingSpecies:9606;CA#:256782
37525413	127	147	pentosan polysulfate	Chemical	MESH:D010426
37525413	157	182	Creutzfeldt-Jakob disease	Disease	MESH:D007562
37525413	184	188	gCJD	Disease	MESH:D007562
37525413	195	200	V180I	ProteinMutation	tmVar:p|SUB|V|180|I;HGVS:p.V180I;VariantGroup:0;CorrespondingGene:5621;RS#:74315408;CorrespondingSpecies:9606;CA#:256782
37525413	201	214	prion protein	Gene	5621
37525413	249	262	prion protein	Gene	5621
37525413	264	267	PrP	Gene	5621
37525413	309	321	sporadic CJD	Disease	MESH:C538481
37525413	377	390	prion protein	Gene	5621
37525413	477	482	V180I	ProteinMutation	tmVar:p|SUB|V|180|I;HGVS:p.V180I;VariantGroup:0;CorrespondingGene:5621;RS#:74315408;CorrespondingSpecies:9606;CA#:256782
37525413	509	536	pentosan polysulfate sodium	Chemical	MESH:D010426
37525413	538	541	PPS	Chemical	MESH:D010426
37525413	587	590	PrP	Gene	5621
37525413	630	633	PPS	Chemical	MESH:D010426
37525413	666	669	PrP	Gene	5621
37525413	742	745	PPS	Chemical	MESH:D010426
37525413	834	839	V180I	ProteinMutation	tmVar:p|SUB|V|180|I;HGVS:p.V180I;VariantGroup:0;CorrespondingGene:5621;RS#:74315408;CorrespondingSpecies:9606;CA#:256782
37525413	923	926	PPS	Chemical	MESH:D010426
37525413	949	952	PPS	Chemical	MESH:D010426
37525413	1034	1038	PrP.	Gene	5621
37525413	1076	1079	PrP	Gene	5621
37525413	1147	1150	PrP	Gene	5621
37525413	1260	1264	PrP.	Gene	5621
37525413	1270	1273	PPS	Chemical	MESH:D010426
37525413	1352	1355	PrP	Gene	5621
37525413	1444	1447	PrP	Gene	5621
37525413	1488	1491	PPS	Chemical	MESH:D010426
37525413	1553	1566	neuronal loss	Disease	MESH:D009410
37525413	1580	1583	PrP	Gene	5621
37525413	1605	1613	cortical	Disease	MESH:D054220
37525413	1614	1621	gliosis	Disease	MESH:D005911
37525413	1654	1665	aquaporin 4	Gene	361
37525413	1745	1748	PPS	Chemical	MESH:D010426
37525413	1778	1781	PPS	Chemical	MESH:D010426
37525413	1816	1819	PrP	Gene	5621
37525413	1865	1868	PPS	Chemical	MESH:D010426
37525413	2052	2057	V180I	ProteinMutation	tmVar:p|SUB|V|180|I;HGVS:p.V180I;VariantGroup:0;CorrespondingGene:5621;RS#:74315408;CorrespondingSpecies:9606;CA#:256782
37525413	2087	2090	PPS	Chemical	MESH:D010426
37525413	2135	2138	PrP	Gene	5621
37525413	2174	2179	V180I	ProteinMutation	tmVar:p|SUB|V|180|I;HGVS:p.V180I;VariantGroup:0;CorrespondingGene:5621;RS#:74315408;CorrespondingSpecies:9606;CA#:256782
37525413	2211	2214	PPS	Chemical	MESH:D010426
37525413	2264	2267	PrP	Gene	5621
37525413	Association	MESH:D007562	RS#:74315408;HGVS:p.V180I;CorrespondingGene:5621
37525413	Negative_Correlation	MESH:D010426	RS#:74315408;HGVS:p.V180I;CorrespondingGene:5621
37525413	Negative_Correlation	MESH:D010426	MESH:D007562
37525413	Negative_Correlation	MESH:D010426	MESH:D054220
37525413	Negative_Correlation	MESH:D010426	MESH:D009410
37525413	Association	MESH:D007562	5621
37525413	Positive_Correlation	MESH:D010426	361
37525413	Association	MESH:D054220	5621
37525413	Positive_Correlation	MESH:D010426	MESH:D005911
37525413	Negative_Correlation	MESH:D010426	5621
37525413	Association	MESH:D009410	5621
37525413	Association	MESH:D005911	5621

